A Study to Assess the Analgesic Efficacy and Safety of ASP0819 in Patients With Fibromyalgia
Clinical trial NCT03056690 · COMPLETED
Trial details
- NCT number
- NCT03056690
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-20
- Primary completion
- 2018-02-27
- Enrollment
- 186
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.